HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Vincenzo Fasanella Selected Research
Vincenzo Fasanella Research Topics
Disease
17
Glaucoma
11/2017 - 07/2008
4
Blister (Bulla)
11/2017 - 06/2008
4
Inflammation (Inflammations)
01/2017 - 06/2011
3
Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2015 - 07/2008
2
Low Tension Glaucoma
01/2018 - 02/2015
2
Macular Degeneration (Age-Related Maculopathy)
01/2015 - 10/2012
2
Choroidal Neovascularization
01/2015 - 10/2012
1
Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
01/2018
1
Dry Eye Syndromes (Dry Eye Syndrome)
03/2015
1
Sexually Transmitted Diseases (Sexually Transmitted Disease)
03/2013
1
Hypersensitivity (Allergy)
02/2013
1
Choroidal Effusions
12/2010
1
Ocular Hypertension (Glaucoma, Suspect)
07/2008
Drug/Important Bio-Agent (IBA)
2
Indicators and Reagents (Reagents)
IBA
10/2016 - 01/2016
2
Biomarkers (Surrogate Marker)
IBA
01/2015 - 06/2013
2
Proteins (Proteins, Gene)
FDA Link
06/2013 - 04/2012
1
Retinaldehyde (Retinal)
IBA
01/2018
1
Cytokines
IBA
01/2017
1
Interleukin-6 (Interleukin 6)
IBA
03/2015
1
HLA-DR Antigens (HLA-DR)
IBA
03/2015
1
Ranibizumab (Lucentis)
FDA Link
01/2015
1
tafluprost
IBA
08/2013
1
Prostaglandins A
IBA
06/2013
1
Fluorescein (Funduscein)
FDA Link
Generic
03/2013
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2012
1
Gold
IBA
12/2010
1
hydroxide ion
IBA
07/2008
1
Antiglaucoma Agents
IBA
06/2008
Therapy/Procedure
10
Therapeutics
03/2015 - 06/2008
6
Lasers (Laser)
11/2017 - 03/2013
6
Filtering Surgery
11/2017 - 06/2011
1
Contact Lenses
02/2015
1
Injections
01/2015
1
Aftercare (After-Treatment)
01/2014